XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 27, 2013
Mar. 28, 2012
Cash flows from operating activities:    
Net income $ 7,081 $ 5,865
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 5,224 6,060
Operating (gains), losses and other charges, net 134 (165)
Amortization of deferred financing costs 133 339
Amortization of debt discount 0 121
Loss on early extinguishment of debt 349 217
Loss on change in the fair value of interest rate cap 2 0
Deferred income tax expense 2,875 3,055
Share-based compensation 1,175 790
Decrease (increase) in assets:    
Receivables 2,398 1,998
Inventories (35) 99
Other current assets 2,218 3,037
Other assets (1,036) (1,064)
Increase (decrease) in liabilities:    
Accounts payable (2,658) (5,389)
Accrued salaries and vacations (5,574) (638)
Accrued taxes (117) (55)
Other accrued liabilities (2,679) (4,414)
Other noncurrent liabilities and deferred credits (2,135) (1,370)
Net cash flows provided by operating activities 7,355 8,486
Cash flows from investing activities:    
Purchase of property (3,006) (1,836)
Proceeds from disposition of property 22 3,594
Collections on notes receivable 1,234 1,367
Issuance of notes receivable (404) (649)
Net cash flows (used in) provided by investing activities (2,154) 2,476
Cash flows from financing activities:    
Long-term debt payments (5,072) (9,137)
Proceeds from exercise of stock options 688 334
Tax withholding on share-based payments (464) (145)
Tax (expense) benefit of stock options exercised (97) 138
Purchase of treasury stock (2,272) 0
Net bank overdrafts (1,286) (2,352)
Net cash flows used in financing activities (8,503) (11,162)
Decrease in cash and cash equivalents (3,302) (200)
Cash and cash equivalents at beginning of period 13,565 13,740
Cash and cash equivalents at end of period $ 10,263 $ 13,540